menu
    • menu

    Company profile for Ranok Therapeutics

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ranok is a privately held, pre-clinical stage biopharmaceutical company that is pioneering an innovative targeted protein degradation technology for the discovery and development of novel therapeutics. Ranok was founded by a leadership team composed of industry veterans from both Chinese and American biotech and pharmaceutical companies and is based in two of the world’s leading centers of innovation and medical research: Ha...
    Ranok is a privately held, pre-clinical stage biopharmaceutical company that is pioneering an innovative targeted protein degradation technology for the discovery and development of novel therapeutics. Ranok was founded by a leadership team composed of industry veterans from both Chinese and American biotech and pharmaceutical companies and is based in two of the world’s leading centers of innovation and medical research: Hangzhou, China and Boston, Massachusetts USA. By bringing together the cutting edges of medical research from both China and the United States

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ranok TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    303 Wyman Street, Suite 300 Waltham, MA 02451
    Telephone
    Telephone
    0571-86630936
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ranoktherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ranok-therapeutics-co-ltd/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/RanokTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ranok Expands Clinical Testing of CHAMP® BRD4 Protein Degrader RNK05047
    Ranok Expands Clinical Testing of CHAMP® BRD4 Protein Degrader RNK05047

    11 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240311598657/en

    BUSINESSWIRE
    11 Mar 2024
    Share Share
    Ranok begins subject dosing in Phase I/II cancer trial
    Ranok begins subject dosing in Phase I/II cancer trial

    25 Aug 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/ranok-dosing-cancer-trial/

    CLINICALTRIALSARENA
    25 Aug 2022
    Share Share
    Ranok Announces Initiation of Dosing in a Phase 1/2 Clinical Trial of RNK05047
    Ranok Announces Initiation of Dosing in a Phase 1/2 Clinical Trial of RNK05047

    24 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220823005879/en

    BUSINESSWIRE
    24 Aug 2022
    Share Share
    FDA Clears Ranok's First-in-Human Trial of RNK05047 in Cancers & Lymphomas
    FDA Clears Ranok's First-in-Human Trial of RNK05047 in Cancers & Lymphomas

    24 Jan 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220124005270/en

    BUSINESSWIRE
    24 Jan 2022
    Share Share
    Ranok Therapeutics Announces Agreement with Pfizer on Targeted Degradation
    Ranok Therapeutics Announces Agreement with Pfizer on Targeted Degradation

    29 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211129005350/en

    BUSINESSWIRE
    29 Nov 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search